Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
140-82-9
17626-34-5
23978-09-8
31249-95-3
23978-55-4
70384-51-9
124043-72-7 | 1-benzofuran-2-sulfonamide | AA000LD6 | MFCD27942489
124276-95-5 | 1-(3-Bromophenyl)cyclopropanecarboxylic acid | AA000LPG | MFCD07374441
1245532-88-0 | Benzoic acid, 3-bromo-2-methoxy-4,5-dimethyl- | AA000M40 | MFCD17167896
1246213-24-0 | 2-(5-(tert-Butyl)-2-hydroxy-4-(4-oxo-1,4-dihydroquinoline-3-carboxamido)phenyl)-2-methylpropanoic acid | AA000ME8 | MFCD26743488
1248406-79-2 | N-Methyl-1-(2-methylpyrimidin-5-yl)methanamine | AA000MP6 | MFCD16665333
1251009-03-6 | tert-Butyl 8-oxo-2,7-diazaspiro[4.4]nonane-2-carboxylate | AA000N2Q | MFCD14581194
125290-87-1 | tert-Butyl (3-methylpyrrolidin-3-yl)methylcarbamate | AA000NDI | MFCD12408552
1255098-82-8 | Ethyl 5-bromo-1h-pyrrolo[3,2-b]pyridine-2-carboxylate | AA000NP0 | MFCD17926298
1256345-94-4 | 2-(t-Butylcarbamoyl)-4-methylphenylboronic acid | AA000NXT | MFCD16036110
1256355-69-7 | 2-(2,4-dichlorophenylmethoxy)phenylboronic acid | AA000O2C | MFCD12463466